Počet záznamov: 1
BNT162b5
SYS d000096106 LBL 00000nx^^^2200181-^^45^^ 005 20240126124500.5 100 $a 20240101asloy0103 ba0 152 $b mesh 250 $a BNT162b5 $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 eng 300 1-
$a 2024 $8 eng 330 1-
$a A combined mRNA vaccine, developed by Pfizer and BioNTech against SARS-CoV-2 with a mixture of the original strain of SARS-CoV-2 and BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2. $8 eng 450 $a COVID-19 Vaccine Pfizer-BioNTech, Bivalent $5 e $8 eng 450 $a COVID-19 vakcína Pfizer-BioNTech, bivalentná $5 e $8 slo 450 $a Pfizer-BioNTech COVID-19 Vaccine, Bivalent $5 e $8 eng 450 $a Pfizer-BioNTech COVID-19 vakcína, bivalentná $5 e $8 slo 686 $a D12.776.828.868.228.500.875 686 $a D20.215.894.815.750 686 $a D20.215.894.865.450.500.875 686 $a D20.215.894.899.085.750 686 $a D23.050.865.450.500.875 750 $a BNT162b5 $8 eng 801 -0
$a SK $b BA006 $c 20240119 801 -2
$a SK $b BA006 $c 20240126 980 $x M
Počet záznamov: 1